Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diastereomeric Salt Formation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102010327B details a cost-effective resolution method for S-(+)-Ketoprofen using a novel amine resolving agent, ensuring high optical purity and scalable manufacturing for pharmaceutical supply chains.
Advanced chiral resolution technology for 2-heterocyclic dihydropyrimidines using binaphthol phosphate. Delivers >99% optical purity for scalable hepatitis B drug manufacturing.
Patent CN102417497A reveals a novel resolution method for Ramelteon intermediates, offering high optical purity and significant cost reduction in pharmaceutical manufacturing.
Patent CN1128785C reveals a novel two-step resolution process for high-purity 1-phenylethylamines, offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN108239091B details a robust chemical resolution for NLG919 precursors. This method offers high optical purity, recoverable reagents, and scalable manufacturing for pharmaceutical supply chains.
Patent CN102010400A details a novel chiral resolution route for Rotigotine intermediates, offering high purity and streamlined manufacturing for reliable pharmaceutical supply chains.
Patent CN118026867B details a high-efficiency chiral resolution for Mirogabalin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN102050800A details a cost-effective chiral resolution method for antidepressant intermediates, replacing complex asymmetric synthesis with scalable salt formation.
Patent CN119285654A enables high-purity Levamisole Hydrochloride production with enhanced yield and significantly reduced costs for global pharmaceutical supply chains and procurement teams.
Patent CN1309121A details efficient chiral resolution of antihistamine intermediates using DPTTA, offering high purity and scalable manufacturing for global supply chains.
Novel resolution method for high-purity chiral pyrazolo isoquinoline. Cost-effective scalable process for PARP inhibitor intermediates ensuring supply chain reliability.
Patent CN101142211B details a robust resolution process for cis-oxathiolane cytosine derivatives, offering significant cost reduction and supply chain reliability for antiviral API manufacturing.
Patent CN114591219A details a water-based resolution process for S-3-aminopiperidine dihydrochloride, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103012264A details a robust resolution method for (R)-3-amino-hexahydro-1H-azepane using tartaric acid, ensuring superior optical purity for ophthalmic antibiotics.
Patent CN102070469A reveals chiral cyclic phosphoric acid resolution for high-purity metoprolol. Significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102321040A details a low-cost resolution method for Linezolid intermediates using chiral acids, offering significant supply chain advantages for API manufacturers.
Patent CN109232220B details a novel chiral resolution method offering high purity and scalable production for pharmaceutical intermediate supply chains.
Patent CN111440121B reveals a high-efficiency chiral resolution method for Tetrandrine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106660949B reveals a safe, scalable chiral resolution method for TRPV1 antagonist intermediates, offering significant cost reduction in API manufacturing.
Novel chiral resolution method for Tetrabenazine using di-p-methylbenzoyltartaric acid. Achieves >99% ee with scalable crystallization for reliable API intermediate supply.